Cytochrome P4502D6 gene polymorphism in Chinese population

被引：0
|
作者：
Tao, Enxiang
Liu, Zhuolin
Chen, Biao
Pan, Xibang
机构：
来源：
Zhonghua Yixue Yichuanxue Zazhi/Chinese Journal of Medical Genetics | 1998年 / 15卷 / 01期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：34 / 37
相关论文
共 50 条
  • [21] Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans
    Gaedigk, A
    Bhathena, A
    Ndjountché, L
    Pearce, RE
    Abdel-Rahman, SM
    Alander, SW
    Bradford, LD
    Leeder, JS
    PHARMACOGENOMICS JOURNAL, 2005, 5 (03): : 173 - 182
  • [22] Regioselective hydroxylation of debrisoquine by cytochrome P4502D6: implications for active site modelling
    Lightfoot, T
    Ellis, SW
    Mahling, J
    Ackland, MJ
    Blaney, FE
    Bijloo, GJ
    De Groot, MJ
    Vermeulen, NPE
    Blackburn, GM
    Lennard, MS
    Tucker, GT
    XENOBIOTICA, 2000, 30 (03) : 219 - 233
  • [23] Inhibition of cytochrome P4502D6 (CYP2D6) by terbinafine (TER) in vitro.
    Abdel-Rahman, SM
    Marcucci, K
    Boge, T
    Gotschall, RR
    Kearns, GL
    Leeder, JS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 135 - 135
  • [24] Effect of nonspecific binding to microsomes and metabolic elimination of buprenorphine on the inhibition of cytochrome P4502D6
    Umeda, S
    Harakawa, N
    Yamamoto, M
    Ueno, K
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2005, 28 (02) : 212 - 216
  • [25] Influence of the cytochrome P4502D6*4 allele on the pharmacokinetics of controlled-release metoprolol
    R. Koytchev
    R.-G. Alken
    V. Vlahov
    V. Kirkov
    R. Kaneva
    U. Thyroff-Friesinger
    E. Rehak
    European Journal of Clinical Pharmacology, 1998, 54 : 469 - 474
  • [26] Erratum: Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans
    A Gaedigk
    A Bhathena
    L Ndjountché
    R E Pearce
    S M Abdel-Rahman
    S W Alander
    L DiAnne Bradford
    J Steven Leeder
    The Pharmacogenomics Journal, 2005, 5 : 276 - 276
  • [27] A sensitive method for determination of cytochrome P4502D6 activity in vitro using bupranolol as substrate
    Appanna, G
    Tang, BK
    Muller, R
    Kalow, W
    DRUG METABOLISM AND DISPOSITION, 1996, 24 (03) : 303 - 306
  • [28] Influence of the cytochrome P4502D6*4 allele on the pharmacokinetics of controlled-release metoprolol
    Koytchev, R
    Alken, RG
    Vlahov, V
    Kirkov, V
    Kaneva, R
    Thyroff-Friesinger, U
    Rehak, E
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (06) : 469 - 474
  • [29] The in vitro interaction of dexmedetomidine with human liver microsomal cytochrome P4502D6 (CYP2D6)
    Rodrigues, AD
    Roberts, EM
    DRUG METABOLISM AND DISPOSITION, 1997, 25 (05) : 651 - 655
  • [30] DRUG-METABOLISM BY HUMAN CYTOCHROME P4502D6 - STUDIES OF THE ENZYME CLONED IN YEAST
    CHING, MS
    ELLIS, SW
    GHABRIAL, HG
    LENNARD, MS
    TUCKER, GT
    SMALLWOOD, RA
    GASTROENTEROLOGY, 1993, 104 (04) : A888 - A888
12345